Clinical Trial

BEP Targeting Strategies in Ethiopia

Study acronym: BEP
Completed
View on ClinicalTrials.gov →
Summary
The goal of this randomized effectiveness study is to evaluate the different targeting strategies for the delivery of balanced energy and protein (BEP) supplements among pregnant women in Addis Ababa, Ethiopia. The main goals of the study are to: 1) determine the effectiveness of two individual-based antenatal BEP targeting strategies for preventing adverse pregnancy outcomes; 2) compare the cost-effectiveness of the universal BEP provision with two individual-based targeting strategies for preventing adverse pregnancy outcomes; and 3) generate implementation evidence regarding the feasibility and acceptability of different antenatal BEP targeting strategies. Pregnant women will be enrolled during pregnancy, assigned to different strategies of BEP supplementation, and followed from pregnancy through six weeks postpartum to evaluate the impacts of different BEP targeting strategies on pregnancy, maternal, and child outcomes.
Protocol Amendment History 3 changes
critical Trial completed 2026-08-15
notable Enrollment increased: 6750 -> 7851 participants 2026-08-15
notable Primary completion pushed: 2026-05-31 -> 2026-07-31 2026-07-08
Trial Details
NCT Number NCT06125860
Lead Sponsor Harvard School of Public Health (HSPH)
Collaborators: Addis Continental Institute of Public Health, George Mason University
Conditions Small for Gestational Age at Delivery, Gestational Weight Gain, Stillbirth, Preterm Birth, Birth Weight, Maternal Anemia in Pregnancy, Before Birth, Neonatal Death, Perinatal Death
Enrollment 7,851 participants
Start Date 2023-08-07
Primary Completion 2026-08-07 (estimated)
Study Completion 2026-08-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-14